MKI67 and diffuse large B-cell lymphoma: This single-center retrospective cohort study investigated whether the expression of Ki-67 could be prognostic when categorized into groups of ≤70% (low Ki-67) and >70% (high Ki-67) in DLBCL patients undergoing first-line therapy with R-CHOP.